top of page
  • Writer's pictureMyBody MyRisk

COVID-19 & Children; natural infection vs. vaccination

Updated: Jan 15, 2022

Apologies, this is not the shortest post...i feel it is of extreme importance I provide real and truthful information to people about the real risk-benefit profile when deciding whether or not to vaccinate your children.

 

When kids contract COVID-19

Symptoms usually last between two to seven days. Children may also show no signs or symptoms (asymptomatic infection). Children with obesity, chronic heart, lung or neurological problems may become more unwell from COVID-19. COVID-19 can be a serious illness for older people, however in children, the infection is usually mild, and the need to stay in hospital is rare.


 

How does COVID-19 affect children?

The virus can infect children, however, they are less likely to have symptoms. Their symptoms are milder and they are less likely to develop severe illness. Children dying from COVID-19 is rare.


Do children spread the virus?

Children, especially younger ones, appear less likely to spread the virus among themselves and to adults.

Most children become infected through contact with an infected adult member of their household. While children can have COVID-19, rates of spread of COVID-19 in schools are very low. Outbreaks in schools are rare.


Most children recover from COVID-19 symptoms within 6 days, shows Lancet studyThe study, based on data reported through a smartphone app by parents and carers, provides the first detailed description of COVID-19 illness in symptomatic school-aged children.


How does Omicron variant affect kids?

"The most recent data estimates that 1% of children with the Omicron variant require admission to hospital."


“Importantly, the published data also suggests that children tend to have less severe cases of COVID-19 than adults,” says Children’s Health Queensland’s Director of Infectious Diseases Julia Clark. “In most cases the virus causes mild or moderate symptoms, which can include fever and cough, but also milder cases of pneumonia sometimes requiring hospitalisation.”

What about children with complex and chronic conditions?

Internationally, data continues to show that children are affected less commonly and less severely than adults by COVID-19. “Even children with serious underlying conditions will mostly only experience a mild illness with COVID-19. This is reinforced by data from liver transplant units and from children’s cancer centres,” Dr Clark said.


Are kids COVID-19 super spreaders?

No.

While we all know kids, especially younger ones, are not great at keeping their hands and bodily fluids to themselves at the best of times, there is so far no evidence to suggest they are so-called super-spreaders of coronavirus (COVID-19).

Are school children causing outbreaks in the community?

No.

Infection rates in children, including in schools, appear to mirror community rates of transmission rather than driving them. Outbreaks within schools and children’s camps increased with the Delta variant, but the vast majority of infections in children still occur in the household.


 

The Senate Select Committee on COVID-19


From the 30th of August to the 10th of October 2021, there were:

  • 21,000 children under 18 infected with COVID-19.

  • 636 children (3% of cases) were admitted to hospital (ONLY 1.26% was hospitalised for medical care, the other 2% was hospitalised for social / welfare reasons)

  • 12 children (0.06% of cases) were admitted to intensive care

  • 0 children (0% of cases) died


And even better results than above have been reported as the split of medical care vs. social care as reason for hospitalisation were teased out...

Results There were 17,474 SARS-CoV-2 infections in children <16 years in NSW during the study period, of whom 11,985 (68.6%) received care coordinated by SCHN. 21% of children infected with SARS-CoV-2 were asymptomatic. For every 100 SARS-CoV-2 infections in children <16 years, 1.26 (95% CI 1.06 to 1.46) required hospital admission for medical care; while 2.46 (95% CI 2.18 to 2.73) required admission for social reasons only. Risk factors for hospitalisation for medical care included age <6 months, a history of prematurity, age 12 to <16 years, and a history of medical comorbidities (aOR 7.23 [95% CI 2.92 to 19.4]). Of 17,474 infections, 15 children (median age 12.8years) required ICU admission; and 294 children required hospital admission due to social or welfare reasons. Conclusion The majority of children with SARS-CoV-2 infection (Delta variant) had asymptomatic or mild disease. Hospitalisation was uncommon and occurred most frequently in young infants and adolescents with comorbidities. More children were hospitalised for social reasons than for medical care. https://www.medrxiv.org/content/10.1101/2021.12.27.21268348v1

Are children at higher risk of 'Long COVID'?

No.

Professor Curtis says given the risk of long COVID in children appears to be relatively low, the decision to vaccinate under-12s is going to be ‘much more difficult’.   ‘It comes down to that difficulty of risk–benefit equations in vaccination and ensuring that the harm of the vaccine is definitely less than the harm of the disease,’ he said. ‘Whilst that’s easy for adults because we know the harms of disease are very high, as we’re saying here, the acute disease in children is mild and long COVID is rare, and not a big problem.   ‘I’m obviously massively in favour of vaccination and, provided we have a safe vaccine, I imagine that one day we will be vaccinating against this because we vaccinate against many things that are relatively mild. But it has to be shown to be very safe before we give it to all the under-12s because the risk of the disease is so low.


Leader of MCRI’s Infectious Diseases Research Group, Nigel Curtis is a Professor of Paediatric Infectious Disease at the University of Melbourne and Head of Infectious Diseases at the Royal Children’s Hospital.


Should I be worried about the prevalence of Multisystem Inflammatory Syndrome in children after being infected with COVID-19?

No.

Multisystem inflammatory syndrome in children (MIS-C, or PIMS-TS) is a very rare but serious condition. In Australia there have been four confirmed And remember, this is what was seen with the Delta variant. It is even less likely with Omicron as the new circulating variant appears to be even more mild. One of the most severe presentations of COVID-19 is a complex multi-system inflammatory condition terms Paediatric Inflammatory Multisystem Syndrome – Temporally Associated with SARS-CoV-2 (or PIMS-TS). It has some features that are similar to other rare auto-inflammation diseases, such as Kawasaki disease. Doctors from around the world don’t know why a very small number of children develop this condition when most other children are not affected. This is an extremely uncommon disease and most children who have developed the condition, including critically ill children, have all made a good recovery. https://www.childrens.health.qld.gov.au/blog-covid-19-and-kids-what-you-need-to-know/

 

CHO says kids dodge worst symptoms as vaxxes open, school pushed back by 2 weeks


Queensland Chief Health Officer John Gerrard has reassured parents they should not be anxious about children being infected with COVID-19, describing the effects on youth as a mild respiratory illness. “For the most part, the children will have only a mild illness very similar to any of the respiratory infections they’ve had in the past,” he said. “So as much as anything else, these two extra weeks give us an opportunity for others who might be at risk to get that third dose [of vaccine]. “If I’m pushing anything, it’s that in particular.” https://www.watoday.com.au/national/queensland/cho-says-kids-dodge-worst-symptoms-as-vaxxes-open-school-pushed-back-20220110-p59n47.html

 

Senator Gerard Rennick questions safety and trial size of the COVID-19 jab for 5-11 year olds in the Senate Select Committee on COVID-19

Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age

"Adverse events from the first dose through 1 month after the second dose were reported by 43.8% of participants who received two 10-μg doses of BNT162b2." "This study describes immunization against SARS-CoV-2 infection with an mRNA vaccine in children younger than 12 years of age and documents the safety, immunogenicity, and efficacy of a Covid-19 vaccine in this population; trials of other vaccines are under way.


Limitations of the study include the lack of longer-term follow-up to assess the duration of immune responses, efficacy, and safety. However, longer-term follow-up from this study, which will continue for 2 years, should provide clarification. This study was also not powered to detect potential rare side effects of BNT162b2 in 5-to-11-year-olds. However, the safety of BNT162b2 observed in the study combined with widespread use of BNT162b2 in older populations should provide reassurance.


Moreover, an expanded cohort of 5-to-11-year-olds is being assessed in the present study, and additional safety assessments are in progress. Further limitations are that concomitant administration of BNT162b2 with other vaccines was not assessed, and cell-mediated responses to immunization are not yet available."

TRIAL DATA FOR 5 TO 11 YEAR OLDS

Vaccines and Related Biological Products Advisory Committee.

https://www.google.com/url?sa=t&source=web&rct=j&url=https://www.fda.gov/media/144245/download&ved=2ahUKEwjigKH0uK31AhVCgOYKHaEaB0EQFnoECAQQAQ&usg=AOvVaw2R0YHnTpPmI-2rqIODPjOZ


Ingredients 'Tromethamine' and 'Trometamol hydrochloride now in Pfizer jabs for 5-11 year olds

When the Food and Drug Administration authorized the emergency use of the Pfizer-BioNTech vaccine in children ages 5 to 11 last month, the agency noted that the pediatric version would be a bit different than the one for adults: a third the size, with a different buffer for added stability.


Pfizer’s pediatric dose also removes extra salt — sodium chloride and potassium chloride — according to Dr. Sandra Fryhofer, the American Medical Association’s liaison to a Centers for Disease Control and Prevention immunization committee. Taken together with the “tris buffer,” she said in an A.M.A. interview, the changes “make the vaccine product more stable at regular refrigerator temperatures for longer periods of time. The kid version vials can be stored unopened in regular refrigerators for up to 10 weeks.”


The ingredient is not specific to Pfizer’s pediatric Covid vaccine doses. Kit Longley, a Pfizer spokesman, said in an email on Saturday that the compound was being used in adult doses as of this month, and that the manufacturing and ingredient list were otherwise unchanged. Tromethamine is also used in Moderna’s Covid vaccine.



How safe is Tromethamine?


Trometamol hydrochloride

Tromethamine hydrochloride is a biologically inert amino alcohol of low toxicity, which buffers carbon dioxide and acids in vitro and in vivo.

What side effects may I notice from receiving this medicine?

Side effects that you should report to your doctor or health care professional as soon as possible:

  • confusion

  • dark urine

  • fast heartbeat

  • general ill feeling or flu-like symptoms

  • light-colored stools

  • pain, redness, or irritation at site where injected

  • right upper belly pain

  • sweating

  • unusually weak or tired

  • yellowing of the eyes or skin

Side effects that usually do not require medical attention (report to your doctor or health care professional if they continue or are bothersome):

  • dizziness

  • feeling anxious

  • increased hunger

  • loss of appetite,

  • nausea

Where should I keep my medicine?

Keep out of the reach of children!


 

Booster shots for kids

The TGA claims they are not looking at a third COVID-19 vaccine dose in kids under 12, however, Pfizer has already begun trialling jabs on the 6 month old to under 5 year old age group, and has already begun to spruik for booster shots in 12-15 year olds.



I can't get past the fact that the ingredients in the kids jabs were changed, yet;

  1. No pre-clinical trials (animal trials) were conducted given the change to the jab formulation.

  2. The jabs rolled out in the adult population are different from this being rolled out in under 12s.

  3. The TGA explained how they review the adult stats first before expanding the trial into the child population, and that's why testing in under 12s could be done so quickly. But if the jab ingredients are different between groups, how can the the results of one small trial drive the anticipated outcomes of another?


This is what we know:

  1. Covid-19 in kids is mild in the vast majority of cases.

  2. Approx. 1 in 5 children who contract COVID-19 are asymptomatic.

  3. The risk of 'Long COVID' is substantially lower in children than expected.

  4. In Australia in 2021, approx. Only 1.26% of cases in children required hospitalisation for medical treatment, and only 0.06% required ICU. No deaths were reported.

  5. Omicron variant is appearing to be more mild. Child hospitalisations are anticipated to reduced to 1%.

  6. Children are not passing COVID-19 to adults, adults are passing COVID-19 onto their kids.

  7. Schools are not driving outbreaks, outbreaks in the community are increasing positive cases in schools.

  8. COVID-19 Outbreaks at schools are rare, and do not contribute to the broader community situation.

  9. School students are poor transmitters of COVID-19 and schools are not 'COVID super-speader' events.

  10. Multisystem Inflammatory Syndrome in children (MIS-C) is a severe complication of COVID-19, however, the risk of MIS-C after COVID infection remains very rare with only 4 cases in Australia in 2021...all children have fully recovered.

  11. In the very small 5-11 year old COVID-19 trial group, there were ZERO severe COVID-19 cases in either side of the trial.

  12. In the very small 5-11 year old COVID-19 trial group, many children reported adverse reactions; the adverse events caused from COVID-19 vaccination occurred at a higher rate than the adverse events caused by COVID-19 disease

  13. Tromethamine has been added to the jabs, but it's potential benefits and /or harms are not well known.

  14. AND LET'S NOT FORGET...EVEN IF JABBED, CHILDREN CAN STILL CONTRACT AND TRANSMIT COVID

 

For those of you who have children under 12...I have 2 questions for you:

  1. Do you think the TGA should be assessing the risk/benefit profile of COVID-19 vaccination of children on anything other than medical information?

  2. Do you agree with the TGA that the benefit of vaccinating children against COVID-19 outweighs the risks?

 

AUSTRALIAN COVID-19 VAX STATS AS OF 06/01/2022 PLEASE DONT LET YOUR CHILDREN BECOME STATISTICS!


IS IT WORTH THE RISK?

SAVE THE DATE!



166 views0 comments
Post: Blog2_Post
bottom of page